Parnax Lab has informed that the Meeting of the Board of Directors of the Company will be held on May 30, 2016 to consider and approve, the Company’s Standalone and Consolidated audited Financial Results for the fourth quarter and year ended on March 31, 2016. In terms of the Code of Conduct for Prevention of Insider Trading in Securities of Parnax Lab, the Trading Window shall remain closed from May 11, 2016 to June 01, 2016 i.e. from the eleventh day of the month following the quarter till 48 hours from the time the results are communicated to the Stock Exchanges on the date of the Meeting.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1935.25 |
| Dr. Reddys Labs. | 1245.50 |
| Cipla | 1438.75 |
| Zydus Lifesciences | 1150.50 |
| Lupin | 2496.05 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: